Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Share News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sensyne Health Lauds Strong Progress As Maiden Loss Deepens On Costs

Mon, 07th Oct 2019 09:29

(Alliance News) - Sensyne Health PLC said Monday it made "strong" progress in its maiden full year, although a surge in listing and development costs led it to a deeper loss.

Sensyne offers artificial intelligence technology for use in clinical studies for new medical products and in patient care.

For the financial year ended April, pretax loss deepened to GBP19.0 million from GBP7.3 million the year prior. Revenue, though still broadly immaterial, expanded to GBP136,000 from GBP81,000 the year before.

Profit was hurt by research & development costs surging to GBP8.3 million from GBP2.3 million the year prior, as well as GBP3.3 million in exceptional costs primarily related to its GBP60 million initial public offering in London in August 2018.

"I am pleased to report strong progress in our first full year reporting period as a public company, achieving a number of important milestones", Sensyne Chief Executive Officer Paul Drayson said.

These achievements include signing its first major pharmaceutical collaboration deal with Bayer AG worth GBP5 million

Separately on Monday, Sensyne announced it signed a partnership with an unnamed Fortune 200 firm and a data infrastructure company to launch and scale its products in the US under licence. The initial focus will be on its gestational diabetes product, GDm-Health.

No financial details of the deal have been provided.

"We are delighted that this innovative trans-Atlantic relationship will lead to the expansion of our digital healthcare applications to US patients and providers," Drayson said.

"By working with these partners, we will be able to accelerate the full potential of these applications which were originally invented in the NHS," Drayson continued. "We are also delighted that these major agreements mark the completion of the last remaining milestone objective that we set at the time of our IPO in August 2018. All our objectives set at that time have now been achieved."

Sensyne also announced on Monday it entered a formal research agreement with the UK Medicines & Healthcare Products Regulatory Agency to validate software algorithms in digital health.

"New techniques using artificial intelligence and machine learning have the potential to improve patient care and accelerate medical research, however they also require the development of new methods to validate them," Drayson said. "As a leading company in the field of clinical AI we are delighted to be working with the UK's regulatory agency on this vital project."

Shares in Sensyne were 3.4% higher at 106.00 pence in London on Monday.

By Ahren Lester; ahrenlester@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
30 May 2022 15:59

UK shareholder meetings calendar - next 7 days

Tuesday 31 May 
GYG PLCAGM
JTC PLCAGM
Lookers PLCAGM
McColl's Retail Group PLCAGM
Microlise Group PLCAGM
PageGroup PLCAGM
Petershill Partners PLCAGM
Sportech PLCAGM
Tekcapital PLCAGM
Wednesday 1 June  
Boku IncAGM
Parsley Box Group PLCAGM
One Media IP Group PLCAGM
United Oil & Gas PLCAGM
Flowtech Fluidpower PLCAGM
Dianomi PLCAGM
Honeycomb Investment Trust PLCGM re combination with Pollen Street Capital
East Imperial PLCAGM
Secure Income REIT PLCAGM
Public Policy Holding Co IncAGM
Thursday 2 June  
Clontarf Energy PLCGM re issue of new shares
HealthBeacon PLCAGM
Friday 3 June  
no events scheduled  
Monday 6 June  
Alphawave IP Group PLCAGM
Minoan Group PLCAGM
Omega Diagnostics Group PLCAGM
Sensyne Health PLCGM re strategic financing
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
19 Apr 2022 17:06

LONDON MARKET CLOSE: Stocks waver as IMF cuts global growth forecast

(Alliance News) - Stocks in London ended lower on Tuesday, following the long Easter weekend, after the IMF warned Russia's invasion of Ukraine will weigh heavily upon global economic growth.

Read more
19 Apr 2022 11:06

AIM WINNERS & LOSERS: Cake Box trading strong; Sensyne falls further

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
19 Apr 2022 10:43

Sensyne Health shares plummet as AIM delisting proposed

(Alliance News) - Sensyne Health PLC shares slump on Tuesday as the company proposed delisting from London's AIM junior market.

Read more
8 Apr 2022 16:58

LONDON MARKET CLOSE: Stocks end week in optimistic mood

(Alliance News) - Stocks in Europe rallied on Friday, ending the week on the front foot, as investors prepare for the start of US earnings season, inflation readings from Germany, the US and UK and a rate decision from Europe's central bank in an action packed week.

Read more
8 Apr 2022 12:18

LONDON MARKET MIDDAY: Stocks set aside hawkish Fed, Russia war fears

(Alliance News) - Stocks in London were higher at midday on Friday shaking off fears over Russia sanctions and a hawkish Federal Reserve.

Read more
8 Apr 2022 12:14

UPDATE: Sensyne Health plunges amid AIM delisting warning

Sensyne Health PLC plummeted on Friday after the biotechnology said the amendments of its note purchase agreement provides an option to cancel the admission of shares to trading on the market.

Read more
8 Apr 2022 11:28

AIM WINNERS & LOSERS: Sensyne Health drops amid AIM delisting warning

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
8 Apr 2022 11:01

Sensyne Health dives as it warns of future; chief executive steps down

(Alliance News) - Shares in Sensyne Health PLC plummeted on Friday after it warned that without further financing it will not be able to continue beyond this month and that its chief executive officer and founder has stepped down.

Read more
4 Feb 2022 16:11

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
31 Jan 2022 11:13

Sensyne reports "disappointing" first half, with revenue decline

Sensyne reports "disappointing" first half, with revenue decline

Read more
26 Jan 2022 12:09

Sensyne shares rise after securing much-needed GBP11 million

Sensyne shares rise after securing much-needed GBP11 million

Read more
26 Jan 2022 11:23

AIM WINNERS & LOSERS: IG Design plunges after profit warning

AIM WINNERS & LOSERS: IG Design plunges after profit warning

Read more
14 Jan 2022 12:24

LONDON MARKET MIDDAY: Stocks edge lower as US bank earnings begin

LONDON MARKET MIDDAY: Stocks edge lower as US bank earnings begin

Read more
14 Jan 2022 11:20

AIM WINNERS & LOSERS: Sensyne Health plunges on liquidation fears

AIM WINNERS & LOSERS: Sensyne Health plunges on liquidation fears

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.